| answer text |
<p>We are aware of supply issues with some insulin products, however the vast majority
are in stock. Comprehensive management guidance on alternative products has been issued
to the National Health Service where needed.</p><p>The medicine supply chain is highly
regulated, complex, and global. Supply disruption is an issue which affects the United
Kingdom, as well as the other countries around the world, and it can have a variety
of causes, including manufacturing issues, problems with access to raw ingredients,
and sudden spikes in demand.</p><p> </p><p>There is a team within the Department that
deals specifically with medicine supply problems. It has well-established tools and
processes to manage medicine supply issues, working closely with the Medicines and
Healthcare products Regulatory Agency, the pharmaceutical industry, NHS England, and
others operating in the supply chain, to help prevent shortages and expedite resupply
as soon as possible, to ensure that the risks to patients are minimised.</p>
|
|
